Company Profile

CytoBioScience Inc (AKA: CytoBioScience GmbH~Cytocentrics)
Profile last edited on: 6/22/2022      CAGE: 7ERA0      UEI: TMLJYJ72X794

Business Identifier: Device used to screen drug formulations
Year Founded
1989
First Award
2017
Latest Award
2017
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3463 Magic Drive Suite 120
San Antonio, TX 78229
   (210) 767-2727
   info@cytobioscience.com
   www.cytobioscience.com
Location: Single
Congr. District: 20
County: Bexar

Public Profile

Previously doing business as CytoBioscience and having a complex history from the outset, the firm has been doing business as InventaBioTech. Originally having moved to San Antonio, TX, from Germany, still known as CytoBioScience, in 2017 the firm went through went through a reverse merger with Fort Collins, CO-based West Mountain Company - a small firm traded on the over-the-counter public markets. After rebranding as InventaBioTech, the business is now traded under the symbol INVB with OTC Markets Group. Inventa sells a device, the CytoPatch, for screening the safety and efficacy of drug formulations, and it also provides contract research services. Founded in 2001 in Germany, CytoBioScience was lured to San Antonio in 2015 by venture capital money and government incentives andhas has raised signficant US VC snce then.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
OTC : INVB
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2017 1 NIH $218,874
Project Title: Dual optimization of solubility and viscosity for protein therapeutics

Key People / Management

  James R Garvin -- Founder, Chief Executive Officer and Board Member

  Stefan Brenner -- Head of Software Development

  David Johnson

  Thomas Knott -- Co-Founder & Chief Scientific Officer